Home › Research › Risk genes beyond APOE
The effects of Arf4 gene knockdown on Alzheimer's amyloid β deposition: Possible role in cognitive resilience
Hemmati S, Wang E, Wang M, Xie B, Salton S, Haroutunian V, Bennett D, Xu P et al.. Research Square, 2026-10-14
Topic: Genetics and APOE
Plain-language summary
Background Studying the factors involved in cellular and cognitive resilience is a crucial step toward designing preventive and targeted therapeutic approaches for Alzheimer’s disease (AD). Methods Systematic analysis of the proteomic landscape in the advanced aging populations identified ADP ribosylation factor 4 (ARF4) as one of the key driver genes associated with resilience among the oldest-old (OO) non-demented individuals. To assess the effects of Arf4 gene knockdown in AD animal models, we generated APP KM670/671NL x PSEN1 Δexon9 (PSAPP)/ Arf4 +/− mice. Results Protein signatures and protein coexpression network modules of the oldest-old (OO) non-demented individuals were identified. Integrative protein network analysis further revealed ARF4 as a top protein driver of OO. Mouse experiments showed that Arf4 knockdown was associated with increased amyloid plaque burden and enhanced microglial activity. The consequence of Arf4 knockdown was an alteration in amyloid precursor protein (APP) localization, which led to variations in mature APP levels. Arf4 knockdown further led to transcriptomic alterations in the mouse brain; most pronounced in pathways associated with immune regulation and microglial homeostasis. Conclusion Based on the exacerbated AD pathological features and transcriptomic alterations observed in Arf4 knockdown animals, ARF4 appears to play a critical role in AD resilience and may represent a potential prognostic factor worthy of further investigation.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hemmati, S., Wang, E., Wang, M., Xie, B., Salton, S., Haroutunian, V., et al. (2026). The effects of Arf4 gene knockdown on Alzheimer's amyloid β deposition: Possible role in cognitive resilience. Research Square. https://doi.org/10.21203/rs.3.rs-11040037/v1
Vancouver
Hemmati S, Wang E, Wang M, Xie B, Salton S, Haroutunian V, et al. The effects of Arf4 gene knockdown on Alzheimer's amyloid β deposition: Possible role in cognitive resilience. Research Square. 2026. doi:10.21203/rs.3.rs-11040037/v1.
BibTeX
@article{hemmati2026-4e8ac976,
author = {Hemmati, S. and Wang, E. and Wang, M. and Xie, B. and Salton, S. and Haroutunian, V. and Bennett, D. and Xu, P. and others},
title = {{The effects of Arf4 gene knockdown on Alzheimer's amyloid β deposition: Possible role in cognitive resilience}},
journal = {Research Square},
year = {2026},
doi = {10.21203/rs.3.rs-11040037/v1},
url = {https://doi.org/10.21203/rs.3.rs-11040037/v1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Methods Systematic analysis of the proteomic landscape in the advanced aging populations identified ADP ribosylation factor 4 (ARF4) as one of the key driver genes associated with resilience among the oldest-old (OO) non-demented individuals.
- Results Protein signatures and protein coexpression network modules of the oldest-old (OO) non-demented individuals were identified.
- Integrative protein network analysis further revealed ARF4 as a top protein driver of OO.
- Mouse experiments showed that Arf4 knockdown was associated with increased amyloid plaque burden and enhanced microglial activity.
- Arf4 knockdown further led to transcriptomic alterations in the mouse brain; most pronounced in pathways associated with immune regulation and microglial homeostasis.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 21 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 13 of the 62 points we could judge it on, which is 21 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (Research Square) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 13 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 13 of the 62 points we could judge it on is 21 out of 100. |
| Total | 21 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk genes beyond APOE from nearby years
Also tagged “single-nucleus”
274 studies in the library carry the topic tag “single-nucleus”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 274 tagged studies.